Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 8Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 6Breast 5Lymphoid 4Genitourinary 3Gastrointestinal 3Thoracic 1Sarcoma 1Plasma cell 1Dermatologic 1

Conditions

Melanoma 467Skin Neoplasms 145Carcinoma, Basal Cell 94Breast Neoplasms 78Neoplasms 68Lymphoma, T-Cell, Cutaneous 62Lung Neoplasms 57Carcinoma, Squamous Cell 40Carcinoma, Non-Small-Cell Lung 40Mycosis Fungoides 39Uveal Melanoma 38Sezary Syndrome 37Lymphoma, Non-Hodgkin 35Lymphoma 35Keratosis, Actinic 35Pancreatic Neoplasms 34Sarcoma 33Prostatic Neoplasms 33Head and Neck Neoplasms 33Colorectal Neoplasms 33Leukemia, Lymphocytic, Chronic, B-Cell 31Ovarian Neoplasms 30Urinary Bladder Neoplasms 29Multiple Myeloma 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Lymphoma, B-Cell, Marginal Zone 28Colonic Neoplasms 28Lymphoma, Mantle-Cell 27Lymphoma, Follicular 27Leukemia 27

Interventions

denileukin diftitox 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Drug-Related Side Effects and Adverse Reactions × Dermatologic × Clear all
NCT05137847 2023-12-12

A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)

Eisai Inc.

Completed
118 enrolled
DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡